INTRODUCTION
============

A novel coronavirus, which was named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by the World Health Organization ([@B1][@B2]), has been isolated from lower respiratory tract specimens ([@B3]). The virus seems more infectious with regard to person-to-person transmission than the well-known 2003 severe acute respiratory syndrome coronavirus (SARS-CoV) ([@B4]). As of May 11, 2020, the global total number of confirmed cases of coronavirus disease (COVID-19) is 4006257 (88891 new cases), with 278892 deaths (4531 new cases), and the highest incidence has been in Europe, with 1731606 confirmed cases (23660 new cases) and 156603 deaths (1051 new cases) ([@B5]).

Similar to other types of coronaviral pneumonia, such as SARS and middle East respiratory syndrome (MERS), COVID-19 can also lead to acute respiratory distress syndrome and even death ([@B6][@B7]). Treatment options vary depending on the severity of the patient\'s condition ([@B8]), and patients with severe and critical cases of COVID-19 have a poor survival prognosis ([@B9]). It is clinically important to identify patients with severe COVID-19 early in the disease course.

Imaging plays an important role in the management of COVID-19 ([@B10]). In the detection of COVID-19, computed tomography (CT) is superior to chest radiography, and some small lesions are not visible on chest radiographs ([@B10][@B11]). Some studies have estimated the severity of COVID-19 based on CT characteristics ([@B12][@B13]) or semiquantitative visual CT scores ([@B14][@B15]). At present, there have been a few quantitative CT studies on COVID-19 ([@B16]). The aim of this study was to use an open-source software platform to compare the accuracy of the clinical classification of the severity of COVID-19 based on quantitative CT parameters and the semiquantitative visual score.

MATERIALS AND METHODS
=====================

The study protocol was approved by the Ethics Committee of Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology. The need for informed consent was waived because of the retrospective nature of the study. The anonymous data were collected and analyzed to facilitate better clinical decision making and treatment.

Patient Selection and Clinical Classification of Severity
---------------------------------------------------------

This study was a retrospective single-center study that included patients who were hospitalized because of the suspicion of a novel coronavirus infection and underwent both chest CT imaging and laboratory virus nucleic acid testing (reverse transcription polymerase chain reaction \[RT-PCR\] assay with throat swab samples) from February 15, 2020, to February 29, 2020. A total of 187 patients (mean age, 57.12 ± 15.57 years; 50.8% \[95/187\] men) were recruited for the analysis. Patients whose poor breath-holding ability led to poor image quality were excluded. The diagnosis of COVID-19 and clinical classification of severity were determined according to the new coronavirus pneumonia diagnosis and treatment plan (trial version 7) developed by the National Health Committee of the People\'s Republic of China ([@B8]). The patients were divided into two groups according to the clinical classification of severity: groups 1 (common) and 2 (severe and critical).

CT Scanning Protocol
--------------------

All images were obtained using one of the three CT systems (uCT 780, United Imaging, Shanghai, China; Optima CT660, GE Healthcare, Milwaukee, WI, USA; Somatom Definition AS+, Siemens Healthineers, Erlangen, Germany) with patients placed in the supine position. The main scanning parameters were as follows: tube voltage, 120 kVp; automatic tube current modulation, 30--70 mAs; pitch, 0.99--1.22 mm; matrix, 512 × 512; slice thickness, 10 mm; and field of view, 350 × 350 mm. All images were then reconstructed with a slice thickness of 0.625--1.250 mm with the same increments.

Imaging Interpretation
----------------------

CT images were reviewed by two radiologists (with 15 and 9 years of experience in cardiothoracic imaging, respectively), who were blinded to the clinical classification results. As part of their initial training, the two radiologists analyzed 10 CT imaging studies and reached a consensus to calibrate the grading thresholds with the scoring systems. Subsequently, they reviewed all chest CT images and resolved discrepancies by discussion until they reached a consensus. The CT characteristics were described using the internationally standard nomenclature defined by the Fleischner Society glossary and peer-reviewed literature on viral pneumonia ([@B17][@B18][@B19]); the terms used were "ground-glass opacity (GGO)," "crazy-paving pattern," and "consolidation" ([Fig. 1A--C](#F1){ref-type="fig"}). In addition to the crazy-paving pattern, a common form of interstitial thickening is the fibrous cord ([Fig. 1D](#F1){ref-type="fig"}).

The readers assessed the presence, location, and density of pulmonary abnormalities on chest CT images and graded the abnormalities using the following semiquantitative visual scoring system ([@B15][@B20][@B21]): score 0, 0% involvement ([Fig. 2A](#F2){ref-type="fig"}); score 1, less than 5% involvement ([Fig. 2B](#F2){ref-type="fig"}); score 2, 5% to 25% involvement ([Fig. 2C](#F2){ref-type="fig"}); score 3, 26% to 49% involvement ([Fig. 2D](#F2){ref-type="fig"}); score 4, 50% to 75% involvement ([Fig. 2E](#F2){ref-type="fig"}); and score 5, greater than 75% involvement ([Fig. 2F](#F2){ref-type="fig"}). Each lobe was assigned a score of 0--5, with a possible total semiquantitative score of 0--25.

Quantitative CT parameters were assessed with the 3D Slicer software (version 4.10.2, <https://www.slicer.org/>), and image segmentation was executed by the two aforementioned radiologists. The pulmonary volume ([Fig. 3D](#F3){ref-type="fig"}) and lesion volume were segmented, and lesion volume was divided into the volume of GGOs ([Fig. 3A, B](#F3){ref-type="fig"}) and that of consolidation ([Fig. 3A, C](#F3){ref-type="fig"}). Subsequently, the volume and mean CT value were calculated. The percentages of lesions, GGOs, and consolidation out of the total lung volume were calculated.

Data Analysis
-------------

The cutoff values for the quantitative CT parameters and semiquantitative visual score were calculated based on the maximum Youden index. Differences in all parameters between groups 1 and 2 were compared with the t test or chi-square test. Spearman\'s correlation was used to detect the correlations between the CT parameters and the clinical classification of severity. The receiver operating characteristic (ROC) curve analysis was used to select the method with superior accuracy in terms of determining the disease severity from among the quantitative CT parameters and semiquantitative visual score. Analyses were performed with the SPSS 25.0 statistical package (IBM Corp., Armonk, NY, USA) and MedCalc version 19.1.3 (MedCalc Software bvba, Mariakerke, Belgium). *P* values \< 0.05 were considered statistically significant.

RESULTS
=======

General Description and Clinical Classification
-----------------------------------------------

Five patients were excluded because of poor image quality. Fifty-nine patients (31.6%) were classified in group 1, while 128 (68.4%) were classified in group 2 on the day of the examination. The mean ages of the two groups were not significantly different; group 1 had a mean age of 55.4 ± 2.3 years, and group 2 had a mean age of 57.9 ± 1.3 years (*p* = 0.303). The sex distributions did not differ between the two groups (*p* = 0.993).

CT Characteristics and Semiquantitative Visual Score of COVID-19
----------------------------------------------------------------

[Table 1](#T1){ref-type="table"} shows the comparison of the imaging characteristics, namely, interstitial thickening, air bronchogram, axial plane distribution, and unilateral or bilateral involvement, between groups 1 and 2. Among the 187 patients with COVID-19, 13 were negative on CT pulmonary imaging ([Fig. 1](#F1){ref-type="fig"}), and all negative patients were in group 1. The lesions were primarily located in the subpleural area, with a possible extension towards the pulmonary hilum in large lesions.

The quantitative CT parameters showed significant differences in the volume (volumes of lesions, GGOs, and consolidation) and percentage of the lesions out of the total lung volume (percentages of lesions, GGOs, consolidation) between groups 1 and 2. [Table 2](#T2){ref-type="table"} shows the comparison of the quantitative CT parameters. Compared to group 1, group 2 had larger values for the volume and percentage of the lesion out of the total lung volume (*p* \< 0.001).

[Table 3](#T3){ref-type="table"} shows the significant differences in the semiquantitative visual score for each lobe and that between groups 1 and 2 (*p* \< 0.001).

Correlation Analysis and ROC Analysis
-------------------------------------

Spearman\'s correlation analysis of the relationships between the imaging parameters (including the quantitative CT parameters and semiquantitative visual score) and the clinical classification of severity showed that the relationship was stronger for quantitative CT parameters than for the semiquantitative visual score ([Table 4](#T4){ref-type="table"}). In addition, the correlation of lesions and GGOs was stronger than that of consolidation in the comparison among the quantitative CT parameters.

[Table 5](#T5){ref-type="table"} shows the cutoff values, sensitivity, specificity, area under the curve (AUC) and 95% confidence interval when the chest CT images of all subjects were assessed with the two different systems: the quantitative CT parameters were more accurate than the semiquantitative visual score for determination of the severity of COVID-19. The results showed that the percentage of lesions had the highest AUC (0.807; 95% confidence interval, 0.744--0.861; *p* \< 0.001) and specificity (93.2%; 95% confidence interval, 83.5--98.1%), and the percentage of GGOs had the highest sensitivity (93.0%; 95% confidence interval, 87.1--96.7%).

We compared the AUCs between the quantitative CT parameters and the semiquantitative visual score ([Fig. 4](#F4){ref-type="fig"}). [Tables 5](#T5){ref-type="table"} and [6](#T6){ref-type="table"} show that the AUC of the quantitative CT parameters was significantly larger than that of the semiquantitative visual score (*p* \< 0.05).

DISCUSSION
==========

The outbreak of COVID-19 has resulted in a global health emergency. COVID-19 shows radiological similarities to SARS and MERS pneumonia ([@B22][@B23][@B24][@B25][@B26]), with a predominance of bilateral GGOs and consolidative lesions in the peripheral lung ([@B27][@B28]).

Treatment strategies are determined by the disease severity ([@B8]), and CT is a reliable modality for determining the disease severity ([@B29]). Previous studies have assessed the severity of COVID-19 through the description of imaging features ([@B12][@B13]), semiquantitative visual scores ([@B14][@B15]), and deep learning algorithms ([@B16]). Deep learning algorithms vary across manufacturers, and the accuracy of automatic segmentation is lower than that of manual segmentation. The results are difficult to generalize. This study used an open-source software platform and confirmed that the correlation between quantitative CT parameters and the severity of COVID-19 was stronger than that between the semiquantitative visual score and the severity of COVID-19. Compared with the semiquantitative visual score, the quantitative CT parameters have superior accuracy.

The quantitative CT parameters of lesion involvement (volume and percentage) in COVID-19 patients were significantly associated with the clinical classification of severity, but the mean density of lesions was not; therefore, we can conclude that the clinical classification of the severity of COVID-19 is related to the degree of involvement but not to the degree of consolidation of pulmonary tissue. We obtained similar results in the correlation analysis, with the correlation coefficient of consolidation (volume and percentage) being significantly lower than those of GGOs and lesions.

In this study, the sensitivity and specificity of the quantitative CT parameters were higher than those of the semiquantitative visual score in terms of the degree of involvement. Therefore, we can conclude that the former has superior accuracy for the clinical classification of severity. The sensitivity of the GGO percentage was the highest, but the specificity was moderate, indicating that some patients had milder disease but larger GGOs; this supports the findings of some studies, which have shown that some patients have moderate CT characteristics but mild or no clinical symptoms at the time of admission and that disease progression occurs in these patients over the next few days ([@B21][@B30]). Therefore, the GGO percentage can not only be used to classify the clinical severity when the severity does not match the degree of involvement but also as a clinical indication for close observation. If the patient\'s condition changes, treatment should be upgraded immediately. Moreover, the specificity of the lesion percentage was the highest, but the sensitivity was moderate. One likely reason is that the lesion percentage more accurately reflects the degree of involvement of lesions and therefore, has a greater specificity. The maximum AUC of the precise quantitative CT parameters was 0.807, while that of the semiquantitative visual score was 0.716, with the difference being significant. Previous studies have shown that the AUC of the semiquantitative visual score is 0.918 ([@B14]) or 0.870 ([@B15]). However, we found that the proportions of patients in group 2 were significantly lower in those two studies than in this study (10.2%, 30.1%, and 68.4%, respectively). Therefore, it can be speculated that the higher proportion of patients in group 2 is the reason for the relatively lower AUC.

There are several limitations to this study. First, this was a single-center study, but our CT images were obtained with three CT scanners from different manufacturers, which reduced the bias that would be caused by using only one scanner. Furthermore, the patients in our study were inpatients, and most patients with mild COVID-19 are not hospitalized. Therefore, the proportion of patients in group 2 was higher than that in group 1. Consequently, the accuracy of classification could be further improved. Finally, this study only evaluated the clinical classification of the severity with CT images and did not analyze the influence of complications, such as hypertension and cardiovascular disease; however, neither the quantitative CT parameters nor the semiquantitative visual score analysis can be used to evaluate complications, so the effect on their comparison was limited.

In conclusion, the classification accuracy of quantitative CT parameters was significantly superior to that of semiquantitative visual score in terms of evaluating the severity of COVID-19. In particular, the clinical classification of the severity of COVID-19 significantly correlated with the quantitative volume-dependent parameters, and their accuracy was significantly superior to that of the semiquantitative visual score. The initial results for quantitative CT parameters in this study are encouraging, and these parameters may be seen as a viable alternative for predicting the severity of COVID-19.
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![CT manifestations of coronavirus disease.\
**A.** Chest CT shows GGO (arrows) under pleura in bilateral upper lobes (arrow). **B.** There is consolidation in left lower lobe extending towards pulmonary hilum (arrows). No air bronchogram is observed within lesion. **C.** Crazy-paving pattern is seen with symmetrical distribution in bilateral lungs (arrows). **D.** Localized fibrous cord is seen in subpleural area of right lower lobe (arrow). CT = computed tomography, GGO = ground-glass opacity](kjr-21-998-g001){#F1}

![5-point scale for coronavirus disease based on CT images.\
**A.** No lesion, score 0. **B.** Focal GGOs in right lower lobe (arrow) with less than 5% involvement, score 1. **C.** Patchy GGOs in left lower lobe (arrow) with 5% to 25% involvement, score 2. **D.** Wedge and strip consolidations in right lower lobe (arrows) with 26% to 49% involvement, score 3. **E.** GGOs combined with consolidation in right lower lobe (arrow) and middle lobes (arrow) with 50% to 75% involvement, score 4. **F.** Bilateral diffuse GGOs combined with consolidation with greater than 75% involvement, score 5.](kjr-21-998-g002){#F2}

![GGOs and consolidation are segmented with 3D Slicer software on CT images.\
**A.** GGO (white arrow) combined with consolidation (black arrow) in subpleural area. **B, C.** Manual delineation of scope of GGO (white arrows) and consolidation (black arrows) by threshold selection. **D.** Entire lesion fused with GGO and consolidation is shown in whole lung volume.](kjr-21-998-g003){#F3}

![ROC curves of quantitative CT parameters and semiquantitative visual score for identification of clinical classification of severity.\
ROC = receiver operating characteristic](kjr-21-998-g004){#F4}

###### Conventional CT Parameters Characteristic of Coronavirus Disease

![](kjr-21-998-i001)

  CT Parameters                         Group 1   Group 2   χ^2^     *P*
  ------------------------------------- --------- --------- -------- ----------
  Imaging characteristic                                    30.448   \< 0.001
   No lesion                            13        0                  
   Ground-glass opacities               30        85                 
   Consolidation                        2         7                  
   Mixed pattern                        14        36                 
  Interstitial thickening                                   8.284    0.016
   No interstitial thickening           51        85                 
   Crazy-paving pattern                 4         25                 
   Interstitial fibrosis                4         18                 
  Air-bronchogram                       1         5         0.636    0.425
  Axial plane distribution                                  35.823   \< 0.001
   No lesion                            13        0                  
   Peripheral                           40        107                
   Inner zone                           1         6                  
   Balance                              5         15                 
  Unilateral or bilateral involvement                       33.476   \< 0.001
   No lesion                            13        0                  
   Unilateral                           13        20                 
   Bilateral                            33        108                

CT = computed tomography

###### Quantitative CT Parameters for Coronavirus Disease

![](kjr-21-998-i002)

  Quantitative CT Parameters                     Group 1          Group 2          *t*      *P*
  ---------------------------------------------- ---------------- ---------------- -------- ----------
  Pulmonary volume (cm^3^)                       3912.4 ± 147.7   3662.2 ± 100.6   1.400    0.164
  Volume of ground-glass opacities (cm^3^)       83.6 ± 18.5      298.5 ± 31.7     -5.849   \< 0.001
  Volume of consolidation (cm^3^)                28.1 ± 5.8       94.9 ± 11.7      -5.366   \< 0.001
  Volume of lesions (cm^3^)                      108.7 ± 21.9     393.4 ± 36.6     -6.683   \< 0.001
  Mean CT value of lung (HU)                     -778 ± 10        -755 ± 7         -1.929   0.056
  Mean CT value of ground-glass opacities (HU)   -644 ± 26        -655 ± 6         0.419    0.677
  Mean CT value of consolidation (HU)            -230 ± 10        -223 ± 7         -0.569   0.570
  Mean CT value of lesions (HU)                  -561 ± 19        -547 ± 15        -0.580   0.563
  Percentage of ground-glass opacities (%)       2.6 ± 0.8        9.9 ± 1.2        -4.943   \< 0.001
  Percentage of consolidation (%)                0.7 ± 0.2        3.2 ± 0.4        -5.289   \< 0.001
  Percentage of lesions (%)                      3.3 ± 1.0        13.0 ± 1.4       -5.622   \< 0.001

###### Semiquantitative Visual Score for Coronavirus Disease

![](kjr-21-998-i003)

  Lobes                    Group 1       Group 2       *t*      *P*
  ------------------------ ------------- ------------- -------- ----------
  Right upper lobe         0.92 ± 0.17   1.64 ± 0.14   -3.363   \< 0.001
  Right middle lobe        0.54 ± 0.15   1.31 ± 0.14   -3.799   \< 0.001
  Right lower lobe         1.54 ± 0.20   2.53 ± 0.14   -4.097   \< 0.001
  Left upper lobe          0.69 ± 0.15   1.60 ± 0.13   -4.723   \< 0.001
  Left lower lobe          1.31 ± 0.19   2.40 ± 0.16   -4.500   \< 0.001
  Semiquantitative score   4.49 ± 0.68   9.59 ± 0.58   -4.919   \< 0.001

###### Spearman\'s Correlation Analysis of Imaging Data and Clinical Classification

![](kjr-21-998-i004)

  Imaging Data                           *r*     *P*
  -------------------------------------- ------- ----------
  Volume of lesions                      0.489   \< 0.001
  Percentage of lesions                  0.495   \< 0.001
  Volume of ground-glass opacities       0.464   \< 0.001
  Percentage of ground-glass opacities   0.476   \< 0.001
  Volume of consolidation                0.349   \< 0.001
  Percentage of consolidation            0.358   \< 0.001
  Semiquantitative score                 0.349   \< 0.001

###### AUC for Severity Classification of COVID-19 Using Quantitative CT Parameters and Semiquantitative Visual Score

![](kjr-21-998-i005)

  Test Result Variable(s)                    Cutoff   Sensitivity (%)   Specificity (%)   Youden\'s Index (%)   AUC                                    
  ------------------------------------------ -------- ----------------- ----------------- --------------------- ------------ ------ ------- ---------- --------------
  Volume of lesions (cm^3^)                  42.018   91.4              85.1--95.6        55.9                  42.4--68.6   47.3   0.804   \< 0.001   0.739--0.858
  Percentage of lesions                      7.477    50.8              41.8--59.7        93.2                  83.5--98.1   44.0   0.807   \< 0.001   0.744--0.861
  Volume of ground-glass opacities (cm^3^)   28.780   92.2              86.1--96.2        54.2                  40.8--67.3   46.4   0.788   \< 0.001   0.722--0.844
  Percentage of ground-glass opacities       0.671    93.0              87.1--96.7        55.9                  42.4--68.8   48.9   0.795   \< 0.001   0.730--0.851
  Semiquantitative score                     2.000    85.9              78.7--91.4        52.5                  39.1--65.7   38.5   0.716   \< 0.001   0.646--0.780

AUC = area under curve, CI = confidence interval

###### Comparison of AUC between Quantitative CT Parameters and Semiquantitative Visual Score

![](kjr-21-998-i006)

  Compared Parameter                                                Difference between AUCs   Standard Error   z       *P*
  ----------------------------------------------------------------- ------------------------- ---------------- ------- --------
  Volume of lesions vs. semiquantitative score                      0.087                     0.0295           2.955   0.0031
  Percentage of lesions vs. semiquantitative score                  0.091                     0.0285           3.198   0.0014
  Volume of ground-glass opacities vs. semiquantitative score       0.072                     0.0318           2.251   0.0244
  Percentage of ground-glass opacities vs. semiquantitative score   0.079                     0.0301           2.617   0.0089
